We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Doqit offers a solution for managing life admin tasks, helping you organize important information, set action dates, and receive timely reminders, ultimately streamlining tasks like insurance renewals and warranties to reduce unnecessary expenses and simplify your life. It provides secure storage and easy access for vital information, transitioning from chaos to simplicity.  Security is also a priority for Doqit. The platform ensures that your sensitive information is stored securely, giving you peace of mind knowing that you can access your important documents and data whenever you need them, all within a few clicks.
days to go: Extended investment: £87,500
Morgan Goodwin is a UK-based company that pioneers the Combined Trading Platform (CTP) category, offering a comprehensive online platform for small businesses engaged in physical goods trading, along with specialized software development services, and a broad-spectrum business consultancy approach aimed at enhancing growth, efficiency, and technological advancement.
days to go: Stretch investment: £788,519
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
UTU is a company dedicated to building the trust infrastructure for the evolving web 3.0. They aim to facilitate safer and more reliable interactions between users and platforms by utilizing a decentralized reputation and reviews protocol. This protocol involves a non-tradable reputation token (UTT) that users can stake to endorse others, leading to positive outcomes. UTU's focus initially lies in Web3 and DeFi apps, where they provide AI-powered tools to curate trust signals and help users engage confidently in various online activities. They offer a range of products, including the UTU Trust Token, Browser Extension, and Trust API/SDK, all aimed at enhancing trust and security in digital interactions.
days to go: Extended investment: £150,000
QED Naval is a technology and project developer of hybrid-tidal energy solutions. The company asserts that tidal energy is 100% renewable and predictable, guaranteeing power throughout the year. It has developed a disruptive, self-deploying, turbine foundation platform called Subhub. The company claims that Subhub saves stakeholders 60% on deployment, operating and maintenance costs, and increases yield, by up to 48%, through its hydrodynamic hull design. It also points out that the UK has 50% of Europe’s tidal energy resource, and a predicted Gross Value Added (GVA) of £1.4 billion by 2030, ranking 2nd globally after Canada in a $76 billion global tidal energy market. QED Naval aims to become a significant contender in this segment. The company will use 20% of the investment towards team building, 70% in project delivery, and 10% towards growth and commercialisation.

Pitch Rated

90%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,049,085
Grid Duck (GD) is an intelligent energy control system. It argues that only 14% of commercial buildings have a Building Management System (BMS) that allows them to switch off appliances when they are not needed automatically. GD is trying to bring the remaining 86% of buildings under its network. It has launched a wireless cloud-based system for companies to manage their energy consumption. Companies can check their energy consumption on an easy-to-use dashboard. GD is also evolving its technology into a self-learning system that supports time-of-use tariffs, demand response and renewables balancing. The company won the 2020 Rushlight Energy Reduction Award, and is ISO27001 certified for cybersecurity with regards to 'Penetration Test'. With the investment received, the company will grow its revenues and invest in New Product Development (NPD).

Pitch Rated

89%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £339,771
Honcho is the UK’s first reverse auction marketplace for financial services that is revolutionising the car insurance market. In a reverse auction, the company works by inviting insurance providers to bid against one another. For just £1 a bid, insurance providers can go head to head to give the customer their best price and helping the latter to avoid any hidden charges and commission. Honcho's first major £830,000 funding round closed in March 2018 with support from crowd investors plus Maven Capital Partners. The company has just launched its first partner integrations, bringing its services to consumers of two major employee benefits platforms plus a major affiliate network. Honcho was selected for the 'Tech Nation Fintech programme 2019.' Honcho will use the investment to diversify its investor base and bring itself to a platform with support for Insurtech businesses, launch offers in other sectors, evolve its role as Platform as a Service (PaaS), and enhance marketing initiatives.

Pitch Rated

86%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,433,325
Drop is a tech-enabled on-demand virtual wine cellar that delivers quality wine to a customer's doorstep within 1 hour. The company asserts that 25% of the UK's 28 million regular wine drinkers are now buying online. Drop feels that its portal is well-equipped to fulfill the demands of its audience. Its app is available on the App Store and Google Playstore. The company has fulfilled over 25,000 orders to over 4,000 customers with over 750 customers having ordered over five times. Drop will use the investment towards technology development, boost its business, and fuel company growth.

Pitch Rated

85%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £533,380
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph